Neuro-Oncology for the Clinical Neurologist-1판

Section 1: Basic principles of neuro-oncology

1. Fundamentals of neuropathology: introduction to neuropathology and molecular diagnostics

2. Surgical considerations for brain and spine tumors

3. Introduction to radiation therapy

4. Evidence-based approaches to chemotherapy for gliomas


Section 2: Neuro-oncology imaging consults

5. Evaluation of a dural-based lesion

6. Evaluation of a supratentorial parenchymal brain lesion

7. Evaluation of an infratentorial lesion

8. Imaging of spinal lesions

9. Evaluation of peripheral nerve lesions


Section 3: Approach to patients with primary and secondary CNS tumors

10. Approach to the meningioma patient

1 11. Approach to the low-grade glioma patient

12. Approach to the high-grade glioma patient

13. Approach to the CNS lymphoma patient

14. Approach to a brain metastasis patient

15. Approach to the leptomeningeal metastases patient

Section 4: Inherited tumor syndromes in neuro-oncology

16. Approach to patients with the neoplasms associated with neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis

17. Approach to the patient with tuberous sclerosis

18. Approach to Von Hippel Lindau, Cowden disease, and other inherited conditions

Section 5: Neurologic complications of cancer

19. Neurologic complications of cancer

20. Paraneoplastic neurologic disorder syndromes

21. Perineural spread of cancer

22. Cancer-associated plexopathy

23. Cancer complications in patients with hematologic malignancies

Section 6: Neurologic complications of radiation therapy

24. Approach to the patient with radiation necrosis

25. Neurologic complications of radiation

26. Uncommon radiation-induced neurologic syndromes

Section 7: Neurologic complications of systemic therapy

27. Approach to the patient with a delayed post-treatment CNS neurotoxicity

28. Approach to chemotherapy-induced peripheral neuropathy

Section 8: Neurologic complications of immune-based cancer therapies

29. Neurologic complications of immune checkpoint inhibitors

30. Neurologic complications associated with CAR T-cell therapy